 | • レポートコード：GIR-2104Z10291 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、経口糖尿病治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口糖尿病治療薬の種類別市場規模（スルホニル尿素剤、メグリチニド、α-グルコシダーゼ阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経口糖尿病治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Abbott、Biocon、Sanofi、Sunpharma、Novartis、Novo Nordisk、Merck、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：スルホニル尿素剤、メグリチニド、α-グルコシダーゼ阻害剤 ・用途別分析2016年-2026年：病院、診療所、その他 ・経口糖尿病治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口糖尿病治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口糖尿病治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口糖尿病治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口糖尿病治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Antidiabetic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oral Antidiabetic Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oral Antidiabetic Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oral Antidiabetic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sulfonylureas
Meglitinides
Alpha-glucosidase inhibitors
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Oral Antidiabetic Drugs market are listed below:
Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oral Antidiabetic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Antidiabetic Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Alpha-glucosidase inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Antidiabetic Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Oral Antidiabetic Drugs Market Size & Forecast
1.4.1 Global Oral Antidiabetic Drugs Sales in Value (2016-2026))
1.4.2 Global Oral Antidiabetic Drugs Sales in Volume (2016-2026)
1.4.3 Global Oral Antidiabetic Drugs Price by Type (2016-2026) & (USD/MT)
1.5 Global Oral Antidiabetic Drugs Production Capacity Analysis
1.5.1 Global Oral Antidiabetic Drugs Total Production Capacity (2016-2026)
1.5.2 Global Oral Antidiabetic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Antidiabetic Drugs Market Drivers
1.6.2 Oral Antidiabetic Drugs Market Restraints
1.6.3 Oral Antidiabetic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Oral Antidiabetic Drugs Product and Services
2.1.4 Eli Lilly Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Oral Antidiabetic Drugs Product and Services
2.2.4 Abbott Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Oral Antidiabetic Drugs Product and Services
2.3.4 Biocon Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Oral Antidiabetic Drugs Product and Services
2.4.4 Sanofi Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sunpharma
2.5.1 Sunpharma Details
2.5.2 Sunpharma Major Business
2.5.3 Sunpharma Oral Antidiabetic Drugs Product and Services
2.5.4 Sunpharma Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Oral Antidiabetic Drugs Product and Services
2.6.4 Novartis Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Oral Antidiabetic Drugs Product and Services
2.7.4 Novo Nordisk Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Oral Antidiabetic Drugs Product and Services
2.8.4 Merck Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Oral Antidiabetic Drugs Product and Services
2.9.4 Pfizer Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oral Antidiabetic Drugs Sales by Manufacturer
3.1 Global Oral Antidiabetic Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral Antidiabetic Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral Antidiabetic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Antidiabetic Drugs Manufacturer Market Share
3.4.2 Top 6 Oral Antidiabetic Drugs Manufacturer Market Share
3.5 Global Oral Antidiabetic Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral Antidiabetic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Antidiabetic Drugs Market Size by Region
4.1.1 Global Oral Antidiabetic Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Oral Antidiabetic Drugs Revenue by Region (2016-2026)
4.2 North America Oral Antidiabetic Drugs Revenue (2016-2026)
4.3 Europe Oral Antidiabetic Drugs Revenue (2016-2026)
4.4 Asia-Pacific Oral Antidiabetic Drugs Revenue (2016-2026)
4.5 South America Oral Antidiabetic Drugs Revenue (2016-2026)
4.6 Middle East and Africa Oral Antidiabetic Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral Antidiabetic Drugs Sales in Volume by Type (2016-2026)
5.2 Global Oral Antidiabetic Drugs Revenue by Type (2016-2026)
5.3 Global Oral Antidiabetic Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral Antidiabetic Drugs Sales in Volume by Application (2016-2026)
6.2 Global Oral Antidiabetic Drugs Revenue by Application (2016-2026)
6.3 Global Oral Antidiabetic Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral Antidiabetic Drugs Sales by Type (2016-2026)
7.2 North America Oral Antidiabetic Drugs Sales by Application (2016-2026)
7.3 North America Oral Antidiabetic Drugs Market Size by Country
7.3.1 North America Oral Antidiabetic Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Oral Antidiabetic Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Antidiabetic Drugs Sales by Type (2016-2026)
8.2 Europe Oral Antidiabetic Drugs Sales by Application (2016-2026)
8.3 Europe Oral Antidiabetic Drugs Market Size by Country
8.3.1 Europe Oral Antidiabetic Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral Antidiabetic Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral Antidiabetic Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Oral Antidiabetic Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Oral Antidiabetic Drugs Market Size by Region
9.3.1 Asia-Pacific Oral Antidiabetic Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral Antidiabetic Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral Antidiabetic Drugs Sales by Type (2016-2026)
10.2 South America Oral Antidiabetic Drugs Sales by Application (2016-2026)
10.3 South America Oral Antidiabetic Drugs Market Size by Country
10.3.1 South America Oral Antidiabetic Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Oral Antidiabetic Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Antidiabetic Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Oral Antidiabetic Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Oral Antidiabetic Drugs Market Size by Country
11.3.1 Middle East & Africa Oral Antidiabetic Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral Antidiabetic Drugs Typical Distributors
12.3 Oral Antidiabetic Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oral Antidiabetic Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral Antidiabetic Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Oral Antidiabetic Drugs Product and Services
Table 6. Eli Lilly Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Major Business
Table 9. Abbott Oral Antidiabetic Drugs Product and Services
Table 10. Abbott Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biocon Basic Information, Manufacturing Base and Competitors
Table 12. Biocon Major Business
Table 13. Biocon Oral Antidiabetic Drugs Product and Services
Table 14. Biocon Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Oral Antidiabetic Drugs Product and Services
Table 18. Sanofi Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sunpharma Basic Information, Manufacturing Base and Competitors
Table 20. Sunpharma Major Business
Table 21. Sunpharma Oral Antidiabetic Drugs Product and Services
Table 22. Sunpharma Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Oral Antidiabetic Drugs Product and Services
Table 26. Novartis Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 28. Novo Nordisk Major Business
Table 29. Novo Nordisk Oral Antidiabetic Drugs Product and Services
Table 30. Novo Nordisk Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Oral Antidiabetic Drugs Product and Services
Table 34. Merck Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Oral Antidiabetic Drugs Product and Services
Table 38. Pfizer Oral Antidiabetic Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Oral Antidiabetic Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 40. Global Oral Antidiabetic Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Oral Antidiabetic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Oral Antidiabetic Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 43. Head Office and Oral Antidiabetic Drugs Production Site of Key Manufacturer
Table 44. Global Oral Antidiabetic Drugs Sales by Region (2016-2021e) & (K MT)
Table 45. Global Oral Antidiabetic Drugs Sales by Region (2021-2026) & (K MT)
Table 46. Global Oral Antidiabetic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Oral Antidiabetic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Oral Antidiabetic Drugs Sales by Type (2016-2021e) & (K MT)
Table 49. Global Oral Antidiabetic Drugs Sales by Type (2021-2026) & (K MT)
Table 50. Global Oral Antidiabetic Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Oral Antidiabetic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Oral Antidiabetic Drugs Price by Type (2016-2021e) & (USD/MT)
Table 53. Global Oral Antidiabetic Drugs Price by Type (2021-2026) & (USD/MT)
Table 54. Global Oral Antidiabetic Drugs Sales by Application (2016-2021e) & (K MT)
Table 55. Global Oral Antidiabetic Drugs Sales by Application (2021-2026) & (K MT)
Table 56. Global Oral Antidiabetic Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Oral Antidiabetic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Oral Antidiabetic Drugs Price by Application (2016-2021e) & (USD/MT)
Table 59. Global Oral Antidiabetic Drugs Price by Application (2021-2026) & (USD/MT)
Table 60. North America Oral Antidiabetic Drugs Sales by Country (2016-2021e) & (K MT)
Table 61. North America Oral Antidiabetic Drugs Sales by Country (2021-2026) & (K MT)
Table 62. North America Oral Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Oral Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Oral Antidiabetic Drugs Sales by Type (2016-2021e) & (K MT)
Table 65. North America Oral Antidiabetic Drugs Sales by Type (2021-2026) & (K MT)
Table 66. North America Oral Antidiabetic Drugs Sales by Application (2016-2021e) & (K MT)
Table 67. North America Oral Antidiabetic Drugs Sales by Application (2021-2026) & (K MT)
Table 68. Europe Oral Antidiabetic Drugs Sales by Country (2016-2021e) & (K MT)
Table 69. Europe Oral Antidiabetic Drugs Sales by Country (2021-2026) & (K MT)
Table 70. Europe Oral Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Oral Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Oral Antidiabetic Drugs Sales by Type (2016-2021e) & (K MT)
Table 73. Europe Oral Antidiabetic Drugs Sales by Type (2021-2026) & (K MT)
Table 74. Europe Oral Antidiabetic Drugs Sales by Application (2016-2021e) & (K MT)
Table 75. Europe Oral Antidiabetic Drugs Sales by Application (2021-2026) & (K MT)
Table 76. Asia-Pacific Oral Antidiabetic Drugs Sales by Region (2016-2021e) & (K MT)
Table 77. Asia-Pacific Oral Antidiabetic Drugs Sales by Region (2021-2026) & (K MT)
Table 78. Asia-Pacific Oral Antidiabetic Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Oral Antidiabetic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Oral Antidiabetic Drugs Sales by Type (2016-2021e) & (K MT)
Table 81. Asia-Pacific Oral Antidiabetic Drugs Sales by Type (2021-2026) & (K MT)
Table 82. Asia-Pacific Oral Antidiabetic Drugs Sales by Application (2016-2021e) & (K MT)
Table 83. Asia-Pacific Oral Antidiabetic Drugs Sales by Application (2021-2026) & (K MT)
Table 84. South America Oral Antidiabetic Drugs Sales by Country (2016-2021e) & (K MT)
Table 85. South America Oral Antidiabetic Drugs Sales by Country (2021-2026) & (K MT)
Table 86. South America Oral Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Oral Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Oral Antidiabetic Drugs Sales by Type (2016-2021e) & (K MT)
Table 89. South America Oral Antidiabetic Drugs Sales by Type (2021-2026) & (K MT)
Table 90. South America Oral Antidiabetic Drugs Sales by Application (2016-2021e) & (K MT)
Table 91. South America Oral Antidiabetic Drugs Sales by Application (2021-2026) & (K MT)
Table 92. Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2016-2021e) & (K MT)
Table 93. Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2021-2026) & (K MT)
Table 94. Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Oral Antidiabetic Drugs Sales by Type (2016-2021e) & (K MT)
Table 97. Middle East & Africa Oral Antidiabetic Drugs Sales by Type (2021-2026) & (K MT)
Table 98. Middle East & Africa Oral Antidiabetic Drugs Sales by Application (2016-2021e) & (K MT)
Table 99. Middle East & Africa Oral Antidiabetic Drugs Sales by Application (2021-2026) & (K MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Oral Antidiabetic Drugs Typical Distributors
Table 103. Oral Antidiabetic Drugs Typical Customers
List of Figures
Figure 1. Oral Antidiabetic Drugs Picture
Figure 2. Global Oral Antidiabetic Drugs Sales Market Share by Type in 2020
Figure 3. Sulfonylureas
Figure 4. Meglitinides
Figure 5. Alpha-glucosidase inhibitors
Figure 6. Global Oral Antidiabetic Drugs Sales Market Share by Application in 2020
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Global Oral Antidiabetic Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Oral Antidiabetic Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Oral Antidiabetic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Oral Antidiabetic Drugs Sales (2016-2026) & (K MT)
Figure 32. Global Oral Antidiabetic Drugs Production Capacity (2016-2026) & (K MT)
Figure 33. Global Oral Antidiabetic Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Oral Antidiabetic Drugs Market Drivers
Figure 35. Oral Antidiabetic Drugs Market Restraints
Figure 36. Oral Antidiabetic Drugs Market Trends
Figure 37. Global Oral Antidiabetic Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Oral Antidiabetic Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Oral Antidiabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Oral Antidiabetic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Oral Antidiabetic Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Oral Antidiabetic Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Oral Antidiabetic Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Oral Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Oral Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Oral Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Oral Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Oral Antidiabetic Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Oral Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Oral Antidiabetic Drugs Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Oral Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Oral Antidiabetic Drugs Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Oral Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Oral Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Oral Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Oral Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Oral Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Oral Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Oral Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Oral Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Oral Antidiabetic Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Oral Antidiabetic Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Oral Antidiabetic Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Oral Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Oral Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Oral Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Oral Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Oral Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Oral Antidiabetic Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の経口血糖降下薬（OAD）治療市場規模・現状・予測（2021年-2027年） Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabet…- 世界のメトトレキサート経口液剤市場 2021：企業別、地域別、種類・用途別 The Methotrexate Oral Solution Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のメルカプトプリン経口液剤市場 2021：企業別、地域別、種類・用途別 The Mercaptopurine Oral Solution Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の経口薄フィルム製剤市場 2021：企業別、地域別、種類・用途別 The Oral Thin Film Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界のIV・経口鉄剤市場 2021：企業別、地域別、種類・用途別 The IV and Oral Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…